spacer
home > ebr > winter 2018 > under lock and key
PUBLICATIONS
European Biopharmaceutical Review

Under Lock and Key

A new approach to early-stage drug development is being pioneered in Cambridge with the establishment of the Milner Therapeutics Institute (1). This collaboration between pharmaceutical companies and a number of academic institutions aims to create an ecosystem for pre-competitive drug discovery by sharing data and other resources. This initiative illustrates how the increasing volume and complexity of biodata is creating the need for new data management models to ensure that researchers can access the information they need, wherever it is stored, within a secure environment.

The Milner Institute has evolved from the research agreement signed in June 2015 between the University of Cambridge, the Wellcome Trust Sanger Institute and the Babraham Institute with the pharma companies AstraZeneca, Astex and GSK. The number of affiliates has since increased to 66 (2).

Having an agreement in place has lowered the barriers of engagement. Where previously the exchange of potential drug molecules between pharma and researchers could take a year, it now takes two to three weeks.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Misha Kapushesky is founder and Chief Executive Officer of biodata management company Genestack. Prior to Genestack, he was Team Leader in Functional Genomics at the European Bioinformatics Institute (EBI), where he led a team developing pioneering bioinformatics data systems to manage and query the data EBI was archiving. The high level of industry interest made Misha realise these tools addressed a significant pain-point. Genestack has since worked closely with leading industry partners to build a bioinformatics infrastructure that makes it easy to find, combine, analyse and visualise data. Misha has participated in and led international consortia applying bioinformatics to medical research.

spacer
Dr Misha Kapushesky
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Prometic Bioseparations are very pleased to introduce their new purpose built ecommerce platform (Webshop)!

Their goal was to build a platform that is easy to navigate, informative and one that makes their products and services easily accessible to researchers and laboratories worldwide. They also wanted to make ordering as quick and easy as possible to meet the needs of the rapidly progressive industry. They have reflected these requirements with an ecommerce store in order to supply high quality products to customers from academia to big pharma.
More info >>

White Papers

Managing GxP Environmental Systems to Ensure Data Integrity

Vaisala Ltd


More info >>

 
Industry Events

IRT Europe Summit

10-11 April 2018, The Hotel Brussels, Belgium

New clinical trial regulations are requiring sponsors to keep tighter oversight than ever before from audit trails to tracking system changes resulting in high costs and trial delays. IRT Europe explores implementation best practices and how interactive response technologies can be utilised to improve supply chain planning and optimise clinical trials.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement